tiprankstipranks
Trending News
More News >
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA

PharmAla Biotech Holdings, Inc. (MDMA) Revenue

Compare
63 Followers

PharmAla Biotech Holdings, Inc. Revenue

PharmAla Biotech Holdings, Inc. had a revenue of 206.44K in the quarter ending Nov 30, 2025, with -22.79%. This bring the company's revenue in the last twelve months to 754.64K, Decreased 24.63%. In the fiscal year ending Dec 31, 2025, PharmAla Biotech Holdings, Inc. had annual revenue of 605.50K with -41.51% growth.
Revenue (ttm)
754.64K
Revenue Growth
-72.51%
P/S Ratio
19.78
Revenue/Employee
Employees
Market Cap
C$11.98M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
605.50K-429.80K+58.49%
Dec 31, 2024
1.04M503.29K+194.60%
Dec 31, 2023
532.00K453.93K+681.45%
Dec 31, 2022
78.07K-7,807,000.00%
Dec 31, 2021